Adma Biologics (ADMA) EBITDA (2011 - 2026)
Adma Biologics' EBITDA was $54.23 million in Q2 2026, up 20.9% from $44.86 million a year earlier but down 9.8% from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) EBITDA (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Adma Biologics' EBITDA was $232.17 million through Jun 30, 2026, up 42.0% year-over-year; for FY2025, it came in at $199.54 million, up 35.7% from FY2024.
- In earlier years, EBITDA was $147.03 million in FY2024 (+390.7%), $29.96 million in FY2023, -$32.25 million in FY2022 and -$52.88 million in FY2021.
- Quarterly EBITDA has moved between -$13.22 million (Q1 2022) and $64.8 million (Q4 2025) over five years.
- Compared with a year earlier, EBITDA has increased for eight straight quarters, with growth averaging 83.4% over the last eight quarters.
- The year-over-year growth in EBITDA has ranged between 8.7% (Q2 2025) and 285.8% (Q3 2024) over the last five years.
- Per Business Quant data, ADMA's EBITDA in the three quarters before Q2 2026 was $60.11 million (Q1 2026), $64.8 million (Q4 2025) and $53.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Adma Biologics | 2.28 Bn | 1.86 Bn | 86.28 Mn | 54.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 54.23 Mn |
| Mar 31, 2026 | 60.11 Mn |
| Dec 31, 2025 | 64.80 Mn |
| Sep 30, 2025 | 53.04 Mn |
| Jun 30, 2025 | 44.86 Mn |
| Mar 31, 2025 | 36.85 Mn |
| Dec 31, 2024 | 40.27 Mn |
| Sep 30, 2024 | 41.58 Mn |
| Jun 30, 2024 | 41.25 Mn |
| Mar 31, 2024 | 23.94 Mn |
| Dec 31, 2023 | 16.34 Mn |
| Sep 30, 2023 | 10.78 Mn |
| Jun 30, 2023 | 1.63 Mn |
| Mar 31, 2023 | 1.22 Mn |
| Dec 31, 2022 | -4.12 Mn |
| Sep 30, 2022 | -7.45 Mn |
| Jun 30, 2022 | -7.45 Mn |
| Mar 31, 2022 | -13.22 Mn |
| Dec 31, 2021 | -11.67 Mn |
| Sep 30, 2021 | -13.01 Mn |
API Access
Adma Biologics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();